98%
921
2 minutes
20
Magnetic resonance imaging (MRI) is an important tool for analysis of deep brain grey matter structures. However, analysis of these structures is limited due to low intensity contrast typically found in whole brain imaging protocols. Herein, we propose a big data registration-enhancement (BDRE) technique to augment the contrast of deep brain structures using an efficient large-scale non-rigid registration strategy. Direct validation is problematic given a lack of ground truth data. Rather, we validate the usefulness and impact of BDRE for multi-atlas (MA) segmentation on two sets of structures of clinical interest: the thalamic nuclei and hippocampal subfields. The experimental design compares algorithms using T1-weighted 3 T MRI for both structures (and additional 7 T MRI for the thalamic nuclei) with an algorithm using BDRE. As baseline comparisons, a recent denoising (DN) technique and a super-resolution (SR) method are used to preprocess the original 3 T MRI. The performance of each MA segmentation is evaluated by the Dice similarity coefficient (DSC). BDRE significantly improves mean segmentation accuracy over all methods tested for both thalamic nuclei (3 T imaging: 9.1%; 7 T imaging: 15.6%; DN: 6.9%; SR: 16.2%) and hippocampal subfields (3 T T1 only: 8.7%; DN: 8.4%; SR: 8.6%). We also present DSC performance for each thalamic nucleus and hippocampal subfield and show that BDRE can help MA segmentation for individual thalamic nuclei and hippocampal subfields. This work will enable large-scale analysis of clinically relevant deep brain structures from commonly acquired T1 images.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747695 | PMC |
http://dx.doi.org/10.1016/j.mri.2019.03.014 | DOI Listing |
J Neurosci
September 2025
Lendület Laboratory of Thalamus Research, HUN-REN Institute of Experimental Medicine; Budapest, Hungary
The paraventricular thalamic nucleus (PVT) integrates subcortical signals related to arousal, stress, addiction, and anxiety with top-down cortical influences. Increases or decreases in PVT activity exert profound, long-lasting effects on behavior related to motivation, addiction and homeostasis. Yet the sources of its subcortical excitatory and inhibitory afferents, their distribution within the PVT, and their integration with layer-specific cortical inputs remain unclear.
View Article and Find Full Text PDFBrain Behav
September 2025
Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University(Tongde Hospital of Zhejiang Province), Hangzhou, China.
Background: Mental disorders frequently co-occur with pain, yet pain mechanisms in non-peripheral etiologies (e.g., chronic psychological stress) remain underexplored.
View Article and Find Full Text PDFTremor Other Hyperkinet Mov (N Y)
September 2025
Movement Disorders and Neurodegenerative Diseases Unit, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Mexico.
Clinical Vignette: RNA polymerase III subunit A (POLR3A) related disorders are a group of heterogeneous diseases with a recessive autosomic inheritance. These disorders manifest with distinct clinical features like ataxia, spasticity, hypodontia, hypogonadism, mental retardation and progressive motor decline.
Clinical Dilemma: POLR3A gene mutation can manifest with parkinsonism, dystonia, ataxia and tremor.
Nat Commun
September 2025
Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
We introduce an advanced transcranial ultrasound stimulation (TUS) system for precise deep brain neuromodulation, featuring a 256-element helmet-shaped transducer array (555 kHz), stereotactic positioning, individualised planning, and real-time fMRI monitoring. Experiments demonstrated selective modulation of the lateral geniculate nucleus (LGN) and connected visual cortex regions. Participants showed significantly increased visual cortex activity during concurrent TUS and visual stimulation, with high cross-individual reproducibility.
View Article and Find Full Text PDFJ Clin Neurophysiol
July 2025
Department of Pediatrics, Division of Pediatric Neurology, Childrens Medical Center Dallas, UTSW, Dallas, Texas, U.S.A.
Open label use of therapies with adult indications raises unique challenges in pediatric DRE. The following review details the landscape of pediatric intracranial neuromodulation. Initially, I discuss available evidence in pediatric neuromodulation while detailing the only randomized clinical trial in a pediatric developmental and epileptic encephalopathy.
View Article and Find Full Text PDF